-
1
The Intersection of Epigenetics and Senolytics in Mechanisms of Aging and Therapeutic Approaches
Published 2024-12-01Subjects: Get full text
Article -
2
Moving from an “anti-aging” paradigm toward the concept of “disease-free aging”: the role of senolytics in modern medicine
Published 2025-01-01“…Senolytic therapy requires strong evidence in human trials, and dasatinib and quercetin have shown good results in phase II trials with idiopathic pulmonary fibrosis and diabetic renal disease. …”
Get full text
Article -
3
Clinical studies with drugs and biologics aimed at slowing or reversing normal aging processes—emerging results and future perspectives
Published 2024-04-01Subjects: Get full text
Article -
4
-
5
Endothelial calcium firing mediates the extravasation of metastatic tumor cells
Published 2025-02-01Get full text
Article -
6
-
7
-
8
Rola marki w procesie podejmowania decyzji zakupu produktów mleczarskich na przykładzie rynku jogurtów
Published 2016-05-01Get full text
Article -
9
The deleterious effects of CDK4/6 inhibition on renal recovery post-acute kidney injury
Published 2024-11-01“…We found that Palb could reverse the senolytic and antifibrotic effects induced by D + Q, which indicates that the profibrotic effect of Palb could be ascribed to its pro-senescent effects. …”
Get full text
Article -
10
MSC-sEVs exacerbate senescence by transferring bisecting GlcNAcylated GPNMB
Published 2025-01-01“…These insights emphasize the necessity of targeting glycosylation modifications of GPNMB in the design of novel senolytic therapies aimed at mitigating cellular ageing and its associated pathologies.…”
Get full text
Article -
11
Fear avoidance beliefs and quality of life quality after lumbar disc surgery
Published 2017-04-01Get full text
Article -
12
Human proximal tubular epithelial cell interleukin-1 receptor signalling triggers G2/M arrest and cellular senescence during hypoxic kidney injury
Published 2025-01-01“…Treatment of Hypoxia+IL-1β-treated PTECs with either a type I IL-1 receptor (IL-1RI) neutralizing antibody or a senolytic drug combination, quercetin+dasatinib, attenuated senescent cell burden. …”
Get full text
Article